CRVO 25 year old man - Factor V Leiden Heterozygous
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 53620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41020/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 46620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 39920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 46020/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 42120/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 50120/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 42520/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 42220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 40320/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 42420/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 44220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 41420/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 40220/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 45620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 40020/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 37720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 39920/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 43620/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 43120/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 46720/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
CRVO 25 year old man - Heterozygous Factor V Leidenvaatamisi: 39820/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.
(0 hinnangut)
|
|
|
|
|
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
